Medical Weight loss
Semaglutide for Weight Loss (Wegovy/Ozempic)
Semaglutide, also known as Wegovy or Ozempic was approved by the FDA in June 2021. It has been used for type II diabetes since 2017. In studies, patient's noted a 15-18% decrease in their body weight, which is more than what has been seen with other weight loss medications. We recommend using this as a tool along with a healthy diet and exercise.
​
How Does Semaglutide Work for Weight Loss?
A GLP-1 is an incretin hormone that plays a role in your appetite and digestion. Incretins — hormones released by your digestive tract — are sent out by your body after you’ve eaten a meal. They help lower your blood sugar by triggering insulin release from the pancreas and blocking sugar production, helping with insulin resistance that can be affecting your ability to lose weight. They also slow down how quickly food leaves your stomach (called gastric emptying).
The result of these actions causes you to feel full — lowering your appetite and causing you to lose weight. Medications like GLP-1 agonists are referred to as incretin mimetics since they “mimic” these effects.
​
If you have been struggling to lose weight, this is just the tool you need to get the weight off. We have helped hundreds of patients over the last year and if you would like to book a consultation, please click this link below:
​
​
​
​
​